Changes in Endothelial Dysfunction and Associated Cardiovascular Disease Morbidity Markers in GH-IGF Axis Pathology

Author： Graham Michael R.   Evans Peter  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.6, 2009-12, pp. : 371-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The GH/IGF-1 Axis in Chronic Heart Failure

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-01 ,pp. : 76-91

Bentham Science Publishers

Access to resources Recommend Favorite

The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 35, 2008-12 ,pp. : 3700-3714

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics

By  

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3827-3841

Bentham Science Publishers

Access to resources Recommend Favorite

Metformin therapy is associated with reduced cardiovascular morbidity and mortality

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 9, 2011-09 ,pp. : 1343-1353

Bentham Science Publishers

Access to resources Recommend Favorite